suramin has been researched along with methotrexate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Kammerer, WS; Perez-Esandi, MV | 1 |
| Chrin, LR; Jaffe, JJ | 1 |
| Hofland, LJ; Lamberts, SW; van Koetsveld, P | 1 |
| Bustamante, A; Henderson, GB; Patel, R; Rideout, DC | 1 |
| Huang, A; Wright, JA | 1 |
10 other study(ies) available for suramin and methotrexate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Chemotherapy of experimental Echinococcus granulosus infection. Trials in CF1 mice and jirds (Meriones unguiculatus).
Topics: Administration, Oral; Alkanesulfonates; Amidines; Amphotericin B; Animals; Echinococcosis; Echinococcus; Female; Fumarates; Gerbillinae; Humans; Injections, Intramuscular; Injections, Intraperitoneal; Iodized Oil; Methotrexate; Methyl Ethers; Mice; Phenyl Ethers; Rifampin; Suramin; Thymol | 1975 |
10-Formyltetrahydrofolate synthetase activity in normal and brugia pahangi-infected Aedes aegypti.
Topics: Aedes; Animals; Brugia; Cysteine; Female; Formate-Tetrahydrofolate Ligase; Kinetics; Ligases; Magnesium; Male; Methotrexate; Molecular Weight; Quaternary Ammonium Compounds; Suramin; Temperature | 1979 |
The interrelationship between the anti-mitotic action of the somatostatin analog octreotide and that of cytostatic drugs and suramin.
Topics: Animals; Antineoplastic Agents; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Kinetics; Methotrexate; Mitosis; Octreotide; Pituitary Neoplasms; Prolactin; Rats; Suramin; Vincristine | 1991 |
Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells.
Topics: Antineoplastic Agents; Biological Transport; Carrier Proteins; Cell Division; Drug Synergism; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Neoplasms; Pyrimethamine; Receptors, Cell Surface; Suramin; Tumor Cells, Cultured | 1995 |
Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
Topics: Animals; Antineoplastic Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Blotting, Southern; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line; Dihydroorotase; DNA; Drug Resistance; Fibroblast Growth Factor 2; Fibroblast Growth Factor 4; Fibroblast Growth Factors; Fibroblasts; Gene Amplification; Hydroxyurea; Methotrexate; Mice; Multienzyme Complexes; Phosphonoacetic Acid; Proto-Oncogene Proteins; Ribonucleotide Reductases; Suramin; Tetrahydrofolate Dehydrogenase; Transfection | 1994 |